{"AllianceGenome": "18364", "HGNC": "18364", "MIM": "607401", "_id": "282616", "_version": 1, "accession": {"genomic": ["AC011445.6", "CH471126.1", "CP068259.2", "CS055921.1", "CS183953.1", "CS364714.1", "DQ126336.2", "FB742068.1", "GM040592.1", "HI658878.1", "HI659149.1", "JB971259.1", "LC822749.1", "LC822750.1", "LC822751.1", "NC_000019.10", "NC_060943.1", "NW_025791808.1"], "protein": ["AAI13582.1", "AAI13584.1", "AAN28263.1", "AAN86126.1", "AAR24510.1", "AAZ38827.1", "AAZ38828.1", "CAI75182.1", "CAJ41835.1", "CAL33801.1", "CAS97663.1", "CAT02301.1", "CBY45347.1", "CBY45407.1", "CDL78889.1", "EAW56870.1", "NP_742150.1", "Q8IZJ0.1", "QNT60867.1", "QNT60868.1"], "rna": ["AA774195.1", "AY129148.1", "AY184373.1", "AY336715.1", "BC113581.1", "BC113583.1", "DQ126337.1", "MN820699.1", "MN820700.1", "NM_172138.2"], "translation": [{"protein": "NP_742150.1", "rna": "NM_172138.2"}, {"protein": "QNT60867.1", "rna": "MN820699.1"}, {"protein": "AAR24510.1", "rna": "AY336715.1"}, {"protein": "AAN28263.1", "rna": "AY129148.1"}, {"protein": "AAI13584.1", "rna": "BC113583.1"}, {"protein": "AAZ38828.1", "rna": "DQ126337.1"}, {"protein": "AAN86126.1", "rna": "AY184373.1"}, {"protein": "AAI13582.1", "rna": "BC113581.1"}, {"protein": "QNT60868.1", "rna": "MN820700.1"}]}, "alias": ["IFNL2a", "IFNL3a", "IL-28A", "IL28A"], "ensembl": [{"gene": "ENSG00000183709", "protein": "ENSP00000333639", "transcript": "ENST00000331982", "translation": [{"protein": "ENSP00000333639", "rna": "ENST00000331982"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000291875", "protein": "ENSP00000517479", "transcript": "ENST00000709041", "translation": [{"protein": "ENSP00000517479", "rna": "ENST00000709041"}], "type_of_gene": "protein_coding"}], "entrezgene": "282616", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.61857561879, "exp_mis": 71.9602346875, "exp_syn": 34.3645123361, "lof_z": -0.146864180309408, "mis_z": 0.631960449184134, "mu_lof": 4.74266540361e-07, "mu_mis": 6.94183568751e-06, "mu_syn": 3.21391232694e-06, "n_lof": 7.0, "n_mis": 61.0, "n_syn": 32.0, "p_li": 1.95487204221475e-05, "p_null": 0.7270388848339, "p_rec": 0.272941566445678, "syn_z": 0.250054973397393}, "bp": 603, "cds_end": 39760653, "cds_start": 39759208, "n_exons": 6, "nonpsych": {"exp_lof": 5.8855776632, "exp_mis": 65.026086417, "exp_syn": 30.9983258439, "lof_z": -0.451135699226214, "mis_z": 0.564569551261613, "mu_lof": 4.74266540361e-07, "mu_mis": 6.94183568751e-06, "mu_syn": 3.21391232694e-06, "n_lof": 7.0, "n_mis": 56.0, "n_syn": 31.0, "p_li": 1.2565854781609e-05, "p_null": 0.798488899926707, "p_rec": 0.201498534218512, "syn_z": -0.000188847314163355}, "nontcga": {"exp_lof": 6.07886744476, "exp_mis": 66.1931983608, "exp_syn": 31.6051282482, "lof_z": -0.368546311078678, "mis_z": 0.562949871901265, "mu_lof": 4.74266540361e-07, "mu_mis": 6.94183568751e-06, "mu_syn": 3.21391232694e-06, "n_lof": 7.0, "n_mis": 57.0, "n_syn": 30.0, "p_li": 1.40143110919505e-05, "p_null": 0.770114369939866, "p_rec": 0.229871615749042, "syn_z": 0.180781388661014}, "transcript": "ENST00000331982.5"}, "exons": [{"cdsend": 39270013, "cdsstart": 39268568, "chr": "19", "position": [[39268395, 39268578], [39268676, 39268858], [39269151, 39269229], [39269487, 39269637], [39269737, 39269821], [39269914, 39270188]], "strand": 1, "transcript": "NM_172138", "txend": 39270188, "txstart": 39268395}], "exons_hg19": [{"cdsend": 39760653, "cdsstart": 39759208, "chr": "19", "position": [[39759035, 39759218], [39759316, 39759498], [39759791, 39759869], [39760127, 39760277], [39760377, 39760461], [39760554, 39760828]], "strand": 1, "transcript": "NM_172138", "txend": 39760828, "txstart": 39759035}], "generif": [{"pubmed": 12469119, "text": "identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family"}, {"pubmed": 12483210, "text": "closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3"}, {"pubmed": 15850793, "text": "IL-28A and IL-29 induced mRNA expression of the antiviral proteins 2',5'-OAS and MxA was abolished by overexpression of SOCS-1"}, {"pubmed": 15899585, "text": "we found IL-28A and IL-29 act similarly to IFNs, but are less effective generally and have activity in a more limited range of cell lines"}, {"pubmed": 16051921, "text": "IECs express functional receptors for IFN-lambdas, which mediate antiviral and antiproliferative signals in IECs, suggesting a potential for therapeutic use in certain viral infections and as (antiproliferative) anticancer therapy"}, {"pubmed": 16146571, "text": "IL-28A antiviral activity is associated with the activation of the JAK-STAT signaling pathway and expression of ISGs."}, {"pubmed": 16478884, "text": "IFN-lambdas are thus able to generate tolerogenic DCs, an activity that could thwart IFN-beta functions"}, {"pubmed": 17367910, "text": "IFNs lambda exhibit several common features with type I IFNs: antiviral activity, antiproliferative activity and in vivo antitumour activity [review]"}, {"pubmed": 19193806, "text": "These data provide direct and compelling evidence that IFN-lambda, through both extracellular and intracellular antiviral mechanisms, inhibits HIV-1 replication in macrophages."}, {"pubmed": 19304895, "text": "recent findings about the biology of IFN-lambdas and their pathophysiological roles in viral infection, cancer, and immune responses of the innate and adaptive arms.[review]"}, {"pubmed": 19798076, "text": "study supports that IFN-lambdas do not influence every type of cell and that membrane-associated variant IFN-lambda R1 expression is not sufficient to ensure cellular sensitivity toward these cytokines."}, {"pubmed": 20235331, "text": "Chronic hepatitis C patients with the rs12979860 CC responder genotype may have a lower endogenous IFN response to the virus."}, {"pubmed": 20576307, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21145813, "text": "In general IL-29 serum levels exceeded IL-28A/B at least twofold, with IL-29 and IL-28A/B levels being significantly higher in carriers of the rs12979860 C allele than in TT homozygous individuals in hepatitis C"}, {"pubmed": 21170333, "text": "In contrast to IL-29, IL-28A is a potent gene repressor in patients with hepatitis C"}, {"pubmed": 21499846, "text": "IL-29/IL-28A suppress herpes simplex virus type 1 (HSV-1) infection of human NT2-N neurons."}, {"pubmed": 22253847, "text": "This study aimed to 1) examine DNA sequences in IL28B surrounding each of the reported associated single nucleotide polymorphisms and the corresponding regions in IL28A."}, {"pubmed": 22560878, "text": "The results show that IL-28A/IL-28AR1 dyad-induced wound healing migration requires NF-kappaB-mediated MMP-9 expression by MAPK activation."}, {"pubmed": 22825757, "text": "p38 MAPK pathway mediates IL-28A-induced cell migration through MMP-9 expression by activating NF-kappaB and AP-1 binding motifs."}, {"pubmed": 22891284, "text": "Plasmacytoid dendritic cells are major producers of IFN-lambda2 (a type III interferon) in response to viral stimulation."}, {"pubmed": 22962576, "text": "Elevated expression of inflammatory cytokines (IL-5, IL-20, and IL-28A) is associated with bladder cancer development."}, {"pubmed": 23207147, "text": "IFN-lambdas can also directly affect T cells through inhibition of the T helper 2 cell (Th2) responses. IFN-lambdas have varying immunomodulatory functions under different physiological conditions"}, {"pubmed": 23652058, "text": "IL-28 genotype was not associated with response to interferon treatment (OR for GT/GG vs. TT, 0.881 (95%CI 0.388 - 2.002); P = 0.762; OR for CT/CC vs. TT, 0.902 (95%CI 0.458 - 1.778); P = 0.766)."}, {"pubmed": 24269996, "text": "Results showed no association between genotypes and alleles of IL28A, IL28B or IL29 polymorphisms and Hepatitis C virus infection."}, {"pubmed": 24385435, "text": "Interferon regulatory factor (IRF)-3 and -7 are the key transcriptional factors for the induction of IL-28A and IL-28B genes, whereas NF-kappaB is an additional requirement for the induction of the IL-29 gene."}, {"pubmed": 24973639, "text": "this study provides evidence for potential IL-28A participation in Behcet's diseaseand its value as a therapeutic agent."}, {"pubmed": 25355870, "text": "These results show that type III interferons (IFN-lambdas) play a critical protective role in human metapneumovirus infection."}, {"pubmed": 26194286, "text": "Studies indicate that the type III interferons (IFNs) or IFN-lambdas consists of four members: IFN-lambda1 (IL-29), IFN-lambda2 (IL28A), IFN-lambda3 (IL-28B) and IFN-lambda4."}, {"pubmed": 26353965, "text": "NS of severe fever with thrombocytopenia syndrome virus inhibited the activity of IFN-alpha1, IFN-beta, IFN-lambda1 and IFN-lambda2 through inhibition of STAT1 phosphorylation."}, {"pubmed": 30402710, "text": "this study shows that interleukin 28A.rs12980602 genotype could be protective against HCV infection among Egyptians"}, {"pubmed": 31121287, "text": "Serum IL-28A levels were significantly elevated in patients with sepsis compared to healthy controls."}, {"pubmed": 31996071, "text": "A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells."}, {"pubmed": 32205851, "text": "IL28A protein homotetramer structure is required for autolysosomal degradation of HCV-NS5A in vitro."}, {"pubmed": 32527925, "text": "Type III interferons disrupt the lung epithelial barrier upon viral recognition."}, {"pubmed": 32557259, "text": "Interleukin-29 and interleukin-28A induce migration of neutrophils in rheumatoid arthritis."}, {"pubmed": 33885337, "text": "Linkage of Lambda Interferons in Protection Against Severe COVID-19."}, {"pubmed": 34899713, "text": "Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1."}, {"pubmed": 35361913, "text": "Serum IL-28A/IFN-lambda2 is linked to disease severity of COVID-19."}, {"pubmed": 35816926, "text": "Assessment of serum interleukin-28 as a biomarker to predict mortality in traumatic patients with sepsis."}, {"pubmed": 36336888, "text": "Lower level of IL-28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV-ACLF."}], "genomic_pos": [{"chr": "19", "end": 39270188, "ensemblgene": "ENSG00000183709", "start": 39268396, "strand": 1}, {"chr": "HG2569_PATCH", "end": 50570, "ensemblgene": "ENSG00000291875", "start": 48778, "strand": 1}], "genomic_pos_hg19": {"chr": "19", "end": 39760732, "start": 39759154, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0002385", "qualifier": "involved_in", "term": "mucosal immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007259", "qualifier": "involved_in", "term": "cell surface receptor signaling pathway via JAK-STAT"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0038196", "pubmed": 30936491, "qualifier": "involved_in", "term": "type III interferon-mediated signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050778", "qualifier": "involved_in", "term": "positive regulation of immune response"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0051607", "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051607", "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0098586", "pubmed": 30936491, "qualifier": "involved_in", "term": "cellular response to virus"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005102", "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005125", "qualifier": "enables", "term": "cytokine activity"}]}, "homologene": {"genes": [[9544, 696117], [9606, 282616]], "id": 138398}, "interpro": [{"desc": "Interferon lambda", "id": "IPR029177", "short_desc": "INF_lambda"}, {"desc": "Interferon lambda superfamily", "id": "IPR038326", "short_desc": "IFN-lambda_sf"}], "ipi": "IPI00218010", "map_location": "19q13.2", "name": "interferon lambda 2", "other_names": ["IFN-lambda-2", "cytokine Zcyto20", "interferon lambda-2", "interleukin 28A (interferon, lambda 2)", "interleukin-28A"], "pantherdb": {"HGNC": "18364", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2450574", "ortholog_type": "O", "panther_family": "PTHR31943", "taxid": 10090, "uniprot_kb": "Q8CGK6"}, {"MGI": "3647279", "ortholog_type": "O", "panther_family": "PTHR31943", "taxid": 10090, "uniprot_kb": "Q4VK74"}, {"RGD": "6493686", "ortholog_type": "O", "panther_family": "PTHR31943", "taxid": 10116, "uniprot_kb": "A0A0G2JWM7"}, {"RGD": "1589046", "ortholog_type": "O", "panther_family": "PTHR31943", "taxid": 10116, "uniprot_kb": "F1M3K4"}, {"Ensembl": "ENSGALG00000047344", "ortholog_type": "O", "panther_family": "PTHR31943", "taxid": 9031, "uniprot_kb": "B4ER10"}], "uniprot_kb": "Q8IZJ0"}, "pathway": {"kegg": [{"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-8854691", "name": "Interleukin-20 family signaling"}], "wikipathways": [{"id": "WP2113", "name": "Type III interferon signaling"}, {"id": "WP4558", "name": "Overview of interferons-mediated signaling pathway"}]}, "pfam": "PF15177", "pharmgkb": "PA134934396", "pharos": {"target_id": 8777, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF271883", "relationship": "is"}, {"id": "GNF271884", "relationship": "is"}, {"id": "GNF271885", "relationship": "is"}, {"id": "GNF271886", "relationship": "is"}, {"id": "GNF271887", "relationship": "is"}, {"id": "GNF271888", "relationship": "is"}, {"id": "GNF271889", "relationship": "is"}, {"id": "GNF271890", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF335742", "relationship": "is"}}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NW_025791808.1"], "protein": "NP_742150.1", "rna": "NM_172138.2", "translation": {"protein": "NP_742150.1", "rna": "NM_172138.2"}}, "reporter": {"HG-U133_Plus_2": ["1552609_s_at", "1552915_at"], "HTA-2_0": "TC19000539.hg.1", "HuEx-1_0": ["3832887", "3861905"], "HuGene-1_1": "8028607", "HuGene-2_1": "16861953"}, "retired": 126261, "summary": "This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28B (IL28B), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). [provided by RefSeq, Jul 2008].", "symbol": "IFNL2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1425474"}, "unigene": "Hs.567792", "uniprot": {"Swiss-Prot": "Q8IZJ0"}}